Elizabeth J. Jones-Harvey

London, ENG SW36JB, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Advances in Colorectal Cancer Cell Biology and Clonal Evolution.

Advances in Colorectal Cancer Cell Biology and Clonal Evolution.

Journal: International journal of molecular sciences

Published: November 13, 2025

Mitotic single-stranded DNA suppression by DDIAS.

Mitotic single-stranded DNA suppression by DDIAS.

Journal: Molecular cell

Published: June 26, 2025

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 20, 2024

Renal replacement and extracorporeal therapies in critical care: current and future directions.

Renal replacement and extracorporeal therapies in critical care: current and future directions.

Journal: Acute medicine

Published: September 25, 2023

Systemic Therapy for Hereditary Breast Cancers.

Systemic Therapy for Hereditary Breast Cancers.

Journal: Hematology/oncology clinics of North America

Published: November 26, 2022

New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer.

New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer.

Journal: Cancer journal (Sudbury, Mass.)

Published: December 14, 2021

Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study.

Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 30, 2021

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

Journal: The Lancet. Oncology

Published: March 11, 2021

The impact of national non-pharmaceutical interventions ('lockdowns') on the presentation of cancer patients.

The impact of national non-pharmaceutical interventions ('lockdowns') on the presentation of cancer patients.

Journal: Ecancermedicalscience

Published: January 01, 2021

Mortality due to cancer treatment delay: systematic review and meta-analysis.

Mortality due to cancer treatment delay: systematic review and meta-analysis.

Journal: BMJ (Clinical research ed.)

Published: November 05, 2020

Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?

Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: September 20, 2020

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.

Journal: JAMA oncology

Published: June 03, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026